Provided by Tiger Fintech (Singapore) Pte. Ltd.

Inovio Pharmaceuticals

2.00
-0.1500-6.98%
Pre-market: 2.040.0400+2.00%07:04 EST
Volume:3.41M
Turnover:6.78M
Market Cap:107.14M
PE:-0.77
High:2.05
Open:2.00
Low:1.90
Close:2.15
52wk High:5.40
52wk Low:1.30
Shares:53.57M
Float Shares:33.07M
Volume Ratio:2.14
T/O Rate:10.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.5888
EPS(LYR):-3.9488
ROE:-140.12%
ROA:-59.30%
PB:3.76
PE(LYR):-0.51

Loading ...

Inovio Shares Sink After Pricing $25M Public Offering

Dow Jones
·
20 hours ago

BUZZ-Inovio Pharma falls on $25 mln stock sale

Reuters
·
Yesterday

Inovio 13.16M share Spot Secondary priced at $1.90

TIPRANKS
·
Yesterday

Inovio Announces Pricing of $25 Million Public Offering

THOMSON REUTERS
·
Yesterday

Inovio Pharmaceuticals Inc - Prices Public Offering of 13,158,000 Shares at $1.90 Each

THOMSON REUTERS
·
Yesterday

Inovio announces common stock offering, no amount given

TIPRANKS
·
Yesterday

BRIEF-Inovio Announces Proposed Public Offering

Reuters
·
Yesterday

Inovio Pharmaceuticals Inc. Stock Rises Monday, Still Underperforms Market

Dow Jones
·
Yesterday

Inovio Q3 net loss widens on non-cash warrant liabilities

Reuters
·
Yesterday

Inovio Pharmaceuticals posts $21.2 million operating loss for Q3 2025

Reuters
·
Yesterday

BRIEF-Inovio Pharmaceuticals Q3 EPS USD -0.87

Reuters
·
Yesterday

Inovio Pharmaceuticals: Expect to Receive File Acceptance by Year End 2025 for Ino-3107

THOMSON REUTERS
·
Yesterday

Inovio Pharmaceuticals: Potential Pdufa Date in Mid-2026 IF Priority Review Request Granted for Ino-3107

THOMSON REUTERS
·
Yesterday

Inovio Pharmaceuticals Q3 EPS $(0.87) Misses $(0.42) Estimate

Benzinga
·
Yesterday

Inovio Pharmaceuticals Inc. Stock Slides 5.8%, Underperforms Peers

Dow Jones
·
Nov 08

Inovio Pharmaceuticals Inc expected to post a loss of 42 cents a share - Earnings Preview

Reuters
·
Nov 08

Inovio Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Nov 05

Inovio Pharmaceuticals Inc. Stock Rises 6.4%, Outperforms Peers

Dow Jones
·
Nov 04

Inovio completes rolling submission of BLA for INO-3107

TIPRANKS
·
Nov 03

Inovio Pharmaceuticals Inc - Expect File Acceptance by Year End 2025, Pdufa Mid-2026

THOMSON REUTERS
·
Nov 03